ATE107516T1 - Pasteurella-impfstoff. - Google Patents

Pasteurella-impfstoff.

Info

Publication number
ATE107516T1
ATE107516T1 AT89905073T AT89905073T ATE107516T1 AT E107516 T1 ATE107516 T1 AT E107516T1 AT 89905073 T AT89905073 T AT 89905073T AT 89905073 T AT89905073 T AT 89905073T AT E107516 T1 ATE107516 T1 AT E107516T1
Authority
AT
Austria
Prior art keywords
toxin
analog
detoxified
pasteurella multocida
vaccine
Prior art date
Application number
AT89905073T
Other languages
English (en)
Inventor
Foged Niels Taekker
Svend Petersen
Original Assignee
Intervet Int Bv
Statens Veterinaere Serumlabor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv, Statens Veterinaere Serumlabor filed Critical Intervet Int Bv
Application granted granted Critical
Publication of ATE107516T1 publication Critical patent/ATE107516T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1242—Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/832—Drug, bio-affecting and body treating compositions involving bacterial toxin that has modified amino acid sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT89905073T 1988-04-12 1989-04-11 Pasteurella-impfstoff. ATE107516T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK199588A DK199588D0 (da) 1988-04-12 1988-04-12 Vaccine

Publications (1)

Publication Number Publication Date
ATE107516T1 true ATE107516T1 (de) 1994-07-15

Family

ID=8109323

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89905073T ATE107516T1 (de) 1988-04-12 1989-04-11 Pasteurella-impfstoff.

Country Status (8)

Country Link
US (2) US5369019A (de)
EP (1) EP0409895B1 (de)
AT (1) ATE107516T1 (de)
AU (1) AU3532089A (de)
DE (1) DE68916424T2 (de)
DK (1) DK199588D0 (de)
IE (1) IE64033B1 (de)
WO (1) WO1989009617A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK199588D0 (da) * 1988-04-12 1988-04-12 Nordisk Droge & Kemikalie Vaccine
AU8195391A (en) * 1990-06-13 1992-01-07 Smithkline Beecham Corporation Pasteurella multocida toxoid vaccines
DK120792D0 (da) * 1992-09-30 1992-09-30 Bioteknologisk Inst Protein
WO1994011024A1 (en) * 1992-11-06 1994-05-26 Regents Of The University Of Minnesota Composition protective against p. multocida pasteurellosis infection
GB0204387D0 (en) * 2002-02-26 2002-04-10 Secr Defence Screening process
US9750797B2 (en) * 2004-06-16 2017-09-05 Virbac Corporation Sustained release vaccine composition
CN1736479A (zh) 2004-08-20 2006-02-22 简茂盛 猪进行性萎缩性鼻炎的预防、治疗与检测
TWI285647B (en) * 2004-08-20 2007-08-21 Univ Nat Chunghsing Prevention, treatment and detection of porcine progressive atrophic rhinitis
CN101496899B (zh) * 2004-08-20 2011-08-24 简茂盛 猪进行性萎缩性鼻炎的预防、治疗与检测
KR101699245B1 (ko) * 2015-12-21 2017-02-13 주식회사 인트론바이오테크놀로지 신규한 파스튜렐라 멀토시다 박테리오파지 Ｐａｓ-ＭＵＰ-1 및 이의 파스튜렐라 멀토시다 균 증식 억제 용도
WO2025157994A1 (en) 2024-01-25 2025-07-31 Intervet International B.V. Vaccine against ruminant respiratory disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293545A (en) * 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
NL8200392A (nl) * 1982-02-03 1983-09-01 Duphar Int Res Werkwijze ter bereiding van een immunogeen van pasteurella multocida.
SE8205892D0 (sv) * 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
DK199588D0 (da) * 1988-04-12 1988-04-12 Nordisk Droge & Kemikalie Vaccine

Also Published As

Publication number Publication date
EP0409895B1 (de) 1994-06-22
EP0409895A1 (de) 1991-01-30
DE68916424D1 (de) 1994-07-28
DE68916424T2 (de) 1994-11-10
DK199588D0 (da) 1988-04-12
WO1989009617A1 (en) 1989-10-19
US6110470A (en) 2000-08-29
AU3532089A (en) 1989-11-03
IE891151L (en) 1989-10-12
IE64033B1 (en) 1995-06-28
US5369019A (en) 1994-11-29

Similar Documents

Publication Publication Date Title
FI883876A0 (fi) Menetelmä rokotteen valmistamiseksi streptokokki-infektioita vastaan
HU9203098D0 (en) Living vaccine
MX9703017A (es) Inmunizacion oral con plantas transgenicas.
ATE359370T1 (de) Heterologe antigene in stämmen zur impfung mit lebendzellen
ATE127345T1 (de) Stressproteine und verwendungen dafür.
ATE107516T1 (de) Pasteurella-impfstoff.
EP0722338A4 (de) Impfstoffe bestehend aus protein- oder peptid-"cochleaten" und deren verwendung zur immunisierung
GB9409985D0 (en) Vaccine against mycobacterial infections
PH23104A (en) Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant
GB1492596A (en) Tetanus toxoid and process for its manufacture
ATE149569T1 (de) Verfahren zur herstellung von impfstoffen oder toxoiden
IE810618L (en) Pasteurella vaccines
AU601415B2 (en) A process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine
Moskophidis et al. Molecular characterization of glycoprotein antigens on surface of Treponema pallidum: comparison with nonpathogenic Treponema phagedenis biotype Reiter
SE8205247D0 (sv) Fiskvacciner
IE921832A1 (en) Fish vaccine
DK230890A (da) Dna-fragment, der koder for et pasteurella multocida-toxin eller for en subsekvens eller analog deraf, ekspressionsvektor, der omfatter dna-fragmentet, mikroorganisme, der udtrykker dette, fremgangsmaade til fremstilling af et pasteurella-multocida-toxin, diagnostisk middel samt anvendelse heraf, vaccine indeholdende et pasteurella-multocida-toxinderivat, anvendelse af pasteurella multocida-t m.m.
ATE159758T1 (de) Azelluläre impfstoffe
SE8303096L (sv) Lagtoxiskt kikhostevaccin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time